Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |